NIH Brain Development Cohorts (NBDC) Biospecimen Access (X01 Clinical Trial Not Allowed)
ID: 349847Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/349847

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-23-229.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering a funding opportunity for access to biospecimens from the Adolescent Brain Cognitive Development (ABCD) Study, a significant longitudinal research initiative aimed at understanding brain development and child health. Investigators can apply for biological samples, including saliva, blood, urine, and teeth, to support studies related to adolescent health; however, no funding is provided through this opportunity, and applicants must secure their own financing. This initiative is crucial for advancing knowledge in child health and development while promoting scientific collaboration, with applications due by May 5, 2026. Interested parties can find more information and application guidelines on the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-23-229-Full-Announcement.html
    PAR-23-229.html
    The Department of Health and Human Services announces a funding opportunity for access to biospecimens from the Adolescent Brain Cognitive Development (ABCD) Study, managed by NIH's Brain Development Cohorts Biorepository. This longitudinal research initiative will collect data from over 11,000 children to explore the interplay between childhood experiences and brain development. Investigators can apply for biological samples including oral fluids, blood, and teeth for studies related to adolescent health. With no funding provided through this opportunity, applicants must secure their own research financing and follow specific application guidelines, adhering to various requirements, including submission deadlines. Key dates for the application process span from September 5, 2023, with the NIH urging early submissions to allow correction of any errors. The initiative aims to advance understanding of child health and development while promoting open scientific collaboration. Successful applications must demonstrate the significance of the proposed research while ensuring that access to biospecimens aligns with ethical considerations surrounding participant consent and potential resource depletion.
    Similar Opportunities
    Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R01-Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity aimed at accelerating child health research through the analysis of existing data from the Adolescent Brain Cognitive Development (ABCD) Study. This initiative encourages researchers to utilize the extensive longitudinal dataset, which includes health, cognitive function, and environmental factors collected from nearly 12,000 youth starting at ages 9-10, to enhance understanding of adolescent health and development. The funding supports R01 grant applications without clinical trials, allowing for budgets of up to $250,000 annually for a maximum of five years, with applications due by May 7, 2025. Interested applicants can find more information and submission guidelines at the NIH website or contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov.
    Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R21-Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study," aimed at enhancing child health research through the analysis of existing data. This grant, with a funding amount of up to $275,000, is intended for short-term exploratory research projects (R21) that utilize comprehensive data collected from nearly 12,000 youth over several years, focusing on mental health, cognitive function, and various social influences. The initiative underscores the importance of innovative statistical methods and interdisciplinary collaboration, reflecting NIH's commitment to data-driven decisions in child health science. Interested applicants must submit their proposals by May 7, 2025, and can find further details and application guidelines at the NIH grants website or contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov.
    Accelerating the Pace of Drug Abuse Research Using Existing Data (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Accelerating the Pace of Drug Abuse Research Using Existing Data" (RFA-DA-24-037), aimed at enhancing the understanding of substance use behaviors and related disorders through innovative analysis of existing datasets. This initiative specifically seeks applications that utilize previously collected social science, behavioral, and neuroimaging data to investigate the etiology and epidemiology of drug use, prevention strategies, and health service utilization, with a focus on leveraging datasets such as the Adolescent Brain Cognitive Development (ABCD) study. The NIH plans to allocate approximately $2 million annually from FY2023 to FY2025, funding 4-6 grants each year, with a maximum budget of $275,000 for two-year projects. Interested applicants can find more information and submit inquiries via grantsinfo@nih.gov, with proposals due by November 15, 2024.
    Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled the Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01), which invites researchers to apply for access to valuable biospecimens collected from an ongoing longitudinal study focused on tobacco use behaviors and health outcomes in the U.S. This initiative primarily provides urine, plasma, serum, and genomic DNA samples to support research relevant to tobacco regulations under the Family Smoking Prevention and Tobacco Control Act. The PATH Study, launched in 2011, plays a crucial role in advancing scientific understanding of tobacco use and its implications for public health. Applications will open on March 30, 2024, and close on October 31, 2026, with evaluations based on alignment with PATH objectives and the merit of proposed research. Interested applicants can find more information and guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Archiving and Documenting Child Health and Human Development Data Sets (R03 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Archiving and Documenting Child Health and Human Development Data Sets (R03 Clinical Trial Not Allowed)" aimed at supporting the archiving and documentation of existing data sets to facilitate secondary analysis by the scientific community. This initiative, under the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), prioritizes the management of data collected with NICHD support, encouraging activities such as data cleaning, harmonization, and the development of user documentation while ensuring adherence to data sharing policies and participant confidentiality. Eligible applicants include a wide range of organizations, with a funding limit of $50,000 available over a maximum of two years, and applications must be submitted by November 17, 2025, with funding anticipated to begin in early 2026. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    NIDDK Central Repository Non-renewable Sample Access (X01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a grant opportunity titled "NIDDK Central Repository Non-renewable Sample Access," aimed at facilitating access to valuable biological samples for research in health-related fields, particularly diabetes, kidney, and digestive diseases. Eligible applicants, including various educational institutions and organizations, can apply for access to non-renewable samples and associated data from significant clinical studies, with the requirement to submit a report from the NIDDK Central Repository documenting sample availability. This initiative promotes equitable distribution of samples and collaboration among researchers to enhance research outcomes, with no funds awarded; instead, access approvals are based on the scientific merit of applications and sample availability. Interested parties should note that the application deadline is June 26, 2025, and are encouraged to engage with the Repository at least six weeks prior to submission for an assessment. For further inquiries, applicants can contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov.
    NIDCR Prospective Observational or Biomarker Validation Study Cooperative Agreement (U01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the National Institute of Dental and Craniofacial Research (NIDCR) for investigator-initiated observational studies or biomarker validation studies that require prospective data collection. This cooperative agreement aims to support research that enhances oral health by generating robust clinical data and validating biomarkers with established preliminary data. The funding is available for projects up to five years, contingent upon NIH appropriations, and emphasizes the significance of the proposed research and the investigator's capability. Interested applicants can find more information and application guidelines at the provided link, with the application due date set for May 7, 2026, and inquiries directed to grantsinfo@nih.gov.
    Maximizing the Scientific Value of the NHLBI Biologic Biospecimen Repository: Scientific Opportunities for Exploratory Research (R21)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Maximizing the Scientific Value of the NHLBI Biologic Biospecimen Repository: Scientific Opportunities for Exploratory Research (R21)" to support exploratory research utilizing existing biospecimens relevant to heart, lung, and blood diseases. This grant aims to enhance the scientific utility of the NHLBI Biologic Specimen Repository by encouraging researchers to generate preliminary data that can inform future studies, with a focus on maximizing the value of stored collections. A total of $1,155,000 is anticipated for competitive awards from FY2023 through FY2025, with individual budgets capped at $75,000 for a maximum two-year project period. Interested applicants must submit their proposals by December 10, 2024, and can reach out to the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further inquiries.
    Basic Neurodevelopmental Biology of Circuits and Behavior (R21 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Basic Neurodevelopmental Biology of Circuits and Behavior (R21 Clinical Trial Not Allowed)," aimed at supporting research projects that investigate the connections between brain circuit maturation and behavioral development in rodents and non-human primates. The initiative seeks to enhance understanding of how brain region interactions evolve during pre- and postnatal development, particularly in relation to cognitive, affective, and social behaviors, while employing innovative methodologies and in vivo neural measures in awake animals. With a funding ceiling of $275,000 over a two-year period, the application deadline is set for January 7, 2025. Interested applicants can find more information and guidelines at the NIH website or contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further inquiries.
    Research Resource for Human Organs and Tissues (U42 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Research Resource for Human Organs and Tissues" through a cooperative agreement mechanism (U42), aimed at supporting a program that provides and facilitates the availability of human tissues and organs for biomedical research. The initiative seeks to enhance the procurement, preservation, and distribution of diverse biospecimens, both normal and diseased, to aid researchers in understanding various diseases and addressing public health priorities. Applicants must demonstrate a proven track record in managing a human tissue and organ research resource, with direct costs capped at $720,000 over a potential five-year project period. The application period opens on December 24, 2024, with a submission deadline of September 25, 2025. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.